[Treatment and monitoring of patients with differentiated cancer of thyroid gland].
There were examined 200 patients aged from 19 to 77 years with differentiated cancer of the thyroid gland (TG). The combined treatment, which included performance of operation, radioiodine therapy and hormonotherapy, was conducted to all the patients. Total and maximum subtotal TG resection was performed in 90% patients, nonradical operation--in 10%, 23% patients were reoperated. Postoperative monitoring according to chart was done with application of dynamic scintigraphy and determination of the thyroglobuline level in the blood serum. The TG residual tissue (RT) was revealed in 61% patients and in 39%--the cancer metastases in the lymphatic nodes. RT of TG was eliminated in 86.8% patients after the first radioiodine therapy course conduction in middle remedial activity (2.79 +/- 0.11) GBq, the metastases devitalization--in 67.9% in middle remedial activity (4.07 +/- 0.12) GBq.
E D
ED
Chebotareva
D A
DA
Dzhuzha
V V
VV
Shishkina
B F
BF
Siniuta
S M
SM
Cheren'ko
M B
MB
Gorobeĭko
V A
VA
Palamarchuk
A I
AI
Sheptukha
N A
NA
Ivanov
V V
VV
Tratsevskiĭ
D000328:Adult; D000368:Aged; D018265:Carcinoma, Papillary, Follicular / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery